Welcome to the press section. If you want to be included in our media database, please send us an email.

BRAIN AG expects double-digit revenue growth in fiscal year 2017/18 despite weak first half year

  • BioIndustrial segment posts year-on-year growth of +4.4% in the first half of 2017/18, BioScience segment declines by -18.4%
  • Total operating performance of BRAIN Group in the second quarter 2017/18 improved by +4.7% compared to the previous quarter, BioIndustrial segment grows by +17.2% quarter-on-quarter
  • M&A transaction of Biocatalysts Ltd. only partially reconciled in BRAIN Group’s results

BRAIN AG acquires majority stake of leading speciality enzyme producer Biocatalysts Ltd.

  • Strengthening of BRAIN’s BioIndustrial segment through expanding access to attractive speciality enzyme markets and cutting edge enzyme production facilities
  • Widening of commercial opportunities through excellent complementary portfolio and technology fit including access to BRAIN’s unique BioArchive and Biocatalyst’s MetXtra metagenomic library
  • More effective targeting of speciality enzymes markets and growth of the global distribution network

BRAIN AG’s Annual Report honoured with iF Design Award

  • BRAIN’s 2015/16 annual report, ‘Engineering Biology’, receives the iF Design Award, bringing its tally of renowned awards to four
  • Annual report was already honoured with a Red Dot Design Award, a Best of Content Marketing (BCM) and a German Designers’ Club (DDC) Award